Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
0
Number of overlapping holdings
0.0%
% of IHE's 34 holdings also in PPH
nan%
% of PPH's 26 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to PPH
 |
ELI LILLY & CO | 26.1% |
|
JOHNSON & JOHNSON | 23.4% |
|
ZOETIS INC | 4.7% |
|
MERCK & CO. INC. | 4.7% |
|
ROYALTY PHARMA PLC CLASS A | 4.6% |
|
VIATRIS, INC. | 4.5% |
|
PFIZER INC | 4.3% |
|
BRISTOL-MYERS SQUIBB CO | 4.1% |
 |
JAZZ PHARMACEUTICALS PLC | 3.4% |
|
CATALENT INC | 3.1% |
IHE Underweight Relative to PPH
|
ACLARIS THERAPEUTICS, INC. | 0.0% |
|
VENTYX BIOSCIENCES, INC. | 0.0% |
|
PHIBRO ANIMAL HEALTH CORP-A | 0.1% |
|
ATEA PHARMACEUTICALS, INC. | 0.1% |
 |
THERAVANCE BIOPHARMA INC | 0.2% |
|
AMYLYX PHARMACEUTICALS, INC. | 0.2% |
|
REVANCE THERAPEUTICS INC | 0.3% |
|
PLIANT THERAPEUTICS, INC. | 0.3% |
|
INNOVIVA, INC. | 0.3% |
|
CASSAVA SCIENCES, INC. | 0.4% |